UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study

Mayo Clinic proceedings, 2016-05, Vol.91 (5), p.567-574

2016

Volltextzugriff (PDF)

2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation

Journal of arrhythmia, 2021-12, Vol.37 (6), p.1389-1426

2021

Volltextzugriff (PDF)

Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation

Journal of the American College of Cardiology, 2018-01, Vol.71 (2), p.122-132

2018

Volltextzugriff (PDF)

Non-Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation: Changing Clinical Practice and Outcomes for Stroke Prevention in a Nationwide Cohort Study

Mayo Clinic proceedings, 2021-01, Vol.96 (1), p.52-65

2021

Volltextzugriff (PDF)

Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?

Journal of the American College of Cardiology, 2015-02, Vol.65 (7), p.635-642

2015

Volltextzugriff (PDF)

Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant Hyperthyroidism

The journal of clinical endocrinology and metabolism, 2020-09, Vol.105 (9), p.2893-2904

2020

Volltextzugriff (PDF)

Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study

Chest, 2020-05, Vol.157 (5), p.1266-1277

2020

Volltextzugriff (PDF)

Stroke prevention in atrial fibrillation

Trends in cardiovascular medicine, 2022-11, Vol.32 (8), p.501-510

2022

Volltextzugriff (PDF)

Using the CHA2DS2-VASc Score for Refining Stroke Risk Stratification in ‘Low-Risk’ Asian Patients With Atrial Fibrillation

Journal of the American College of Cardiology, 2014-10, Vol.64 (16), p.1658-1665

2014

Volltextzugriff (PDF)

Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage

Circulation (New York, N.Y.), 2016-04, Vol.133 (16), p.1540-1547

2016

Volltextzugriff (PDF)

Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulació

Europace (London, England), 2017-11, Vol.19 (11), p.1757-1758

2017

Volltextzugriff (PDF)

Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation

Annals of internal medicine, 2019-05, Vol.170 (9), p.663

2019

Volltextzugriff (PDF)

Clinical utility and prognostic implications of the 4S‐AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry

European journal of clinical investigation, 2022-10, Vol.52 (10), p.e13825-n/a

2022

Volltextzugriff (PDF)

Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study

European heart journal. Cardiovascular pharmacotherapy, 2023-12, Vol.9 (8), p.681-691

2023

Volltextzugriff (PDF)

Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry

BMC medicine, 2024-04, Vol.22 (1), p.151-151, Article 151

2024

Volltextzugriff (PDF)

The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis-a nationwide cohort study

BMC medicine, 2024-03, Vol.22 (1), p.113-113, Article 113

2024

Volltextzugriff (PDF)

Association between antithrombotic drug regimen changes and clinical outcomes after stroke in atrial fibrillation

Heart rhythm, 2024-07

2024

Volltextzugriff (PDF)

Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation

Clinical research in cardiology, 2022, Vol.111 (1), p.23-33

2022

Volltextzugriff (PDF)

Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation

Chest, 2020-05, Vol.157 (5), p.1266-1277

2020

Volltextzugriff (PDF)

Non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation patients with concomitant peripheral artery disease

European heart journal. Cardiovascular pharmacotherapy, 2021-01, Vol.7 (1), p.50-58

2021

Volltextzugriff (PDF)

Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study

European heart journal. Cardiovascular pharmacotherapy, 2023-08, Vol.9 (5), p.403-412

2023

Volltextzugriff (PDF)

Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis

Journal of clinical medicine, 2020-04, Vol.9 (4), p.1234

2020

Volltextzugriff (PDF)

Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation – A Nationwide Cohort Study

Scientific reports, 2017-04, Vol.7 (1), p.46445-46445, Article 46445

2017

Volltextzugriff (PDF)

Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis

Cardiovascular drugs and therapy, 2019-12, Vol.33 (6), p.701-710

2019

Volltextzugriff (PDF)

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants

Cardiovascular diabetology, 2020-05, Vol.19 (1), p.63-63, Article 63

2020

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

ThemaStroke

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study

2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation

Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation

Non-Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation: Changing Clinical Practice and Outcomes for Stroke Prevention in a Nationwide Cohort Study

Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?

Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant Hyperthyroidism

Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study

Stroke prevention in atrial fibrillation

Using the CHA2DS2-VASc Score for Refining Stroke Risk Stratification in ‘Low-Risk’ Asian Patients With Atrial Fibrillation

Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage

Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation

Clinical utility and prognostic implications of the 4S‐AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry

Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study

Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry

The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis-a nationwide cohort study

Association between antithrombotic drug regimen changes and clinical outcomes after stroke in atrial fibrillation

Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation

Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation

Non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation patients with concomitant peripheral artery disease

Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study

Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis

Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation – A Nationwide Cohort Study

Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants

Aktive Filter

Suchergebnisse filtern